+919405117673
Yurpeak (tirzepatide) KwikPen: what patients should know

Prescription-only medicine. This page is general education for patients and caregivers. It is not medical advice and does not replace your doctor, pharmacist or the patient leaflet in your pack. Never start, change or stop a medicine without speaking to a registered medical practitioner.


A plain-language overview of Yurpeak, a once-weekly injection pen available in India on prescription, including how it is stored, common side effects and when to seek help.

What is Yurpeak?

Yurpeak is a brand name of tirzepatide, a prescription medicine given by injection under the skin. According to company announcements, Cipla launched Yurpeak in India in December 2025 as the second brand of Eli Lilly’s tirzepatide, for obesity and type 2 diabetes. Lilly manufactures and supplies the product, which contains the same active ingredient as Mounjaro.

It comes in a prefilled KwikPen, a pen-style injector designed for self-administration after training from a healthcare professional. Pack strengths differ, and the strength and schedule that suit you are decided only by your doctor.

Who decides if it is right for you

A doctor assesses your health history, current medicines and treatment goals before prescribing. Medicines for weight management and diabetes work best alongside the diet, activity and follow-up plan your care team sets with you.

Safety information

This is a summary, not a complete list. Read the patient information leaflet and prescribing information approved for India for full details.

Side effects reported with this type of medicine

Stomach and digestive effects are among the most commonly reported. They include:

  • Nausea, vomiting or diarrhoea
  • Constipation or stomach discomfort
  • Reduced appetite

Contact your doctor promptly if you have

  • Severe or lasting stomach pain, with or without vomiting
  • Signs of dehydration, such as very dark urine, dizziness or extreme thirst
  • Symptoms of low blood sugar, particularly if you also take insulin or certain other diabetes medicines
  • Swelling of the face, lips or throat, rash or trouble breathing, which need emergency care
  • Pain in the upper right abdomen, yellowing of the skin or eyes

Tell your doctor before treatment if

  • You are pregnant, planning pregnancy or breastfeeding
  • You have had pancreatitis, gallbladder or kidney problems
  • You or a family member has had thyroid cancer
  • You take other medicines, supplements or herbal products

Suspected side effects can be reported to your doctor or through India’s Pharmacovigilance Programme of India (PvPI).

Storage and handling

Product listings state that the Yurpeak KwikPen should be stored in a refrigerator at 2 to 8 °C and not frozen. Follow the exact in-use and travel storage instructions printed in your pack leaflet, and keep pens out of children’s reach. Used needles must be disposed of safely in a sharps container.

Getting it safely

  • Obtain it only against a valid prescription and from a licensed pharmacy.
  • Be wary of unusually cheap offers, unlabelled pens or sellers who skip the prescription. Counterfeit and mishandled injectables can be dangerous.
  • Do not share pens or needles with anyone, even family.

Frequently asked questions

Can I buy Yurpeak without a prescription?

No. It is a prescription-only medicine and should be used under a registered medical practitioner’s supervision.

Is Yurpeak the same as Mounjaro?

They share the same active ingredient, tirzepatide. Yurpeak is Cipla’s brand, with Lilly manufacturing and supplying it.

What should I do if I miss a dose?

Do not guess. Follow the missed-dose guidance in your leaflet or ask your doctor or pharmacist what to do for your prescribed schedule.

How should I store the pen?

In a refrigerator at 2 to 8 °C, never frozen, as described above and in your pack leaflet.

Where can I find official product information?

In the patient leaflet inside the pack, from your pharmacist, or from the manufacturer’s official prescribing information for India.

Sources

This content is for information only and is not a substitute for professional medical advice, diagnosis or treatment. It does not advertise or promote a prescription medicine to the public. Always consult a qualified healthcare professional about your condition. Brand names belong to their respective owners; this page is not affiliated with Cipla or Eli Lilly unless stated by the publisher.

Nov 18th, 2026 7:12 PM

Keywords